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Edited by Peter BrzezinskiAbstract Resonance Raman spectra have been measured to
characterize the heme environment in aldoxime dehydratase
(OxdA), a novel hemoprotein, which catalyzes the dehydration of
aldoxime into nitrile. The spectra showed that the ferric heme in
the enzyme is six-coordinate low spin, whereas the ferrous heme
is ﬁve-coordinate high spin. We assign a prominent vibration that
occurs at 226 cm1 in the ferrous enzyme to the Fe-proximal
histidine stretching vibration. In the CO-bound form of OxdA,
the correlation between the Fe–CO stretching (512 cm1) and C–
O stretching (1950 cm1) frequencies also supports our assign-
ment of proximal histidine coordination.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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We have extensively studied the biological metabolism of
toxic compounds (that have a triple bond between carbon and
nitrogen) such as nitriles [R–CBN] [1–5] and isonitriles [R–
NBC] [6,7]. The microbial degradation of nitriles proceeds
through two diﬀerent enzymatic pathways [8–10]: (i) nitrilase
catalyzes the hydrolysis of nitriles into acids [R–C(@O)–OH]
and ammonia [11–13]; and (ii) nitrile hydratase (NHase)
catalyzes the hydration of nitriles to amides [R–C(@O)–NH2]
[14–17], which are subsequently hydrolyzed to acids and
ammonia by amidase [18–20]. These enzymes have received
much attention in applied ﬁelds [2,8,21] as well as academic
ones [13,22–26]. One of the fruits of our application-oriented
nitrile studies is the current industrial production of acryl-
amide and nicotinamide using NHase of an actinomycete,* Corresponding author. Fax: +81-29-853-4605 (Institute).
1 These authors contributed equally to the results of this work.
Abbreviations: NHase, nitrile hydratase; OxdA(CO), the CO-bound
form of OxdA; HRP, horseradish peroxidase; Hb, hemoglobin; Sw
Mb, sperm whale myoglobin; Mt Hb, Mycobacterium tuberculosis
hemoglobin; Pc Hb, Paramecium caudatum hemoglobin; Rm FixL*,
soluble truncated domain of Rhizobium meliloti FixL; HO, heme-
bound heme oxygenase; sGC, soluble guanylate cyclase
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doi:10.1016/j.febslet.2004.05.008Rhodococcus rhodochrous J1 [1,9]. On the other hand, NHase
of Pseudomonas chlororaphis B23 [27], which was previously
used as a catalyst for acrylamide manufacture [9,21,28], is
now used for the production of 5-cyanovaleramide, a herbi-
cide intermediate, at the industrial level [29]. We have already
cloned the NHase gene from this strain and discovered the
existence of a gene cluster including the NHase and amidase
genes [30].
Very recently, we discovered a gene (oxdA) encoding a novel
nitrile-synthesizing enzyme (aldoxime dehydratase) upstream
of the NHase and amidase genes in P. chlororaphis B23 [31].
The amino acid sequence of OxdA shows similarity (32%
identity) with that of Bacillus phenylacetaldoxime dehydratase
[32]. OxdA [31] and phenylacetaldoxime dehydratase are novel
heme proteins including protoheme IX as the prosthetic group.
These enzymes catalyze a unique and intriguing reaction:
formation of a carbon–nitrogen triple bond and dehydration
of a substrate [R–CH@N–OH] in spite of the presence of water
in the reaction mixture. This reaction is not only academically
interesting but also expected to be applicable to the practical
production of nitriles because it is performed under mild
conditions in contrast with chemical dehydration of aldoximes
under harsh conditions [33]. It was previously reported that rat
liver microsomal cytochromes P450 and P450 3A4 [34] (the
major P450 isozyme in human liver), whose sequence exhibits
no similarity to that of the aldoxime dehydratase family
(comprising OxdA and phenylacetaldoxime dehydratase), also
catalyze the dehydration of aldoxime; but their catalytic ac-
tivities are not so high. It is noteworthy that these aldoxime
dehydration reactions would involve the direct approach of the
substrate to the heme iron in the microsomal P450s [34] or
OxdA [31], in contrast with various other reactions (e.g., mo-
nooxygenation) of general hemoproteins. Although the P450
enzymes are known to have cysteine as the proximal ligand
[34], the heme environmental structure (including a proximal
ligand) of the aldoxime dehydratase family remains unknown.
In the present study, for the ﬁrst time, we characterized
the heme environment in OxdA using resonance Raman
spectroscopy.2. Materials and methods
2.1. Expression and puriﬁcation of recombinant OxdA
OxdA was overexpressed as described previously [31] with a few
improvements. Escherichia coli BL21-CodonPlus(DE3)-RIL wasation of European Biochemical Societies.
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with reciprocal shaking at 37 C in 800 ml of 2 YT medium con-
taining 50 lg/ml kanamycin and 34 lg/ml chloramphenicol. After
overnight cultivation, the entire culture was inoculated into 80 l of the
same medium, followed by incubation with shaking at 37 C for 2 h.
IPTG was then added to a ﬁnal concentration of 0.1 mM to induce
the T7 promoter and further cultivation was carried out at 20 C for
30 h.
OxdA was puriﬁed from the E. coli transformant expressing
OxdA by a modiﬁcation of the previously reported procedure
[31]. All steps were performed at 0–4 C. Potassium phosphate
buﬀer (pH 7.0) without 2-mercaptoethanol was used throughout the
puriﬁcation. Centrifugation was carried out for 30 min at
15 000 g.
The cells were harvested by centrifugation, washed twice with 100
mM buﬀer, and then disrupted by sonication (Insonator Model
201M; Kubota, Tokyo, Japan) to prepare a cell-free extract. Cell
debris was removed by centrifugation. The resulting supernatant was
fractionated with ammonium sulfate (35–60% saturation), followed
by dialysis against 10 mM buﬀer. The dialyzed solution was applied
to a DEAE–Sephacel column (5 25 cm) (Amersham Biosciences,
Piscataway, NJ) equilibrated with 10 mM buﬀer. Protein was eluted
from the column with 2.0 liters of 10 mM buﬀer, the concentration of
KCl being increased linearly from 0.1 to 0.5 M. This operation on
the DEAE–Sephacel column was separately performed twice because
of the capacity limitation. The active fractions were collected and
then ammonium sulfate was added to give 20% saturation. The en-
zyme solution was placed on a TSK gel Butyl-Toyopearl 650 M
column (5 25 cm) (Tosoh Co., Tokyo, Japan) equilibrated with 10
mM buﬀer 20% saturated with ammonium sulfate. The enzyme was
eluted by lowering the concentration of ammonium sulfate (20–0%)
in 2.0 l of the same buﬀer. This operation on the Butyl-Toyopearl
column was separately performed twice because of the capacity
limitation. The active fractions were combined and then precipitated
with ammonium sulfate at 70% saturation. The precipitate was col-
lected by centrifugation, dissolved in 0.1 M buﬀer, and then dialyzed
against three changes of 5 l of 1 mM buﬀer (pH 6.8). After centri-
fugation, the enzyme solution was loaded on a Celluloﬁne HAp
column (5 25 cm) (Seikagaku Kogyo Co., Tokyo, Japan) equili-
brated with 1 mM buﬀer (pH 6.8). The column was eluted with a
linear gradient, 1–100 mM, of the buﬀer (pH 6.8). The resultant
solution was dialyzed against 10 mM buﬀer and then centrifuged.
The active fractions were collected and then ammonium sulfate was
added to give 70% saturation. After centrifugation of the suspension,
the precipitate was dissolved in 0.1 M buﬀer and then dialyzed
against 10 mM buﬀer. The homogeneity of the puriﬁed protein was
conﬁrmed by SDS–PAGE.14
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c2.2. Analytical methods
The heme content was estimated by the pyridine ferrohemochrome
method as previously reported [31]. Protein concentrations were de-
termined with a Nakalai Tesque Co., Inc. (Kyoto, Japan) protein assay
kit, with bovine serum albumin as the standard.
The reduction of OxdA was carried out by adding a few grains of
sodium dithionite to the isolated OxdA. CO gas was introduced into
the OxdA solution by means of a gastight syringe.17001600150014001300
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Fig. 1. High-frequency regions of resonance Raman spectra of the
puriﬁed OxdA (a), the ferrous form (b), and the CO adduct (c). The
spectra were acquired as described in Section 2, using 413.1 nm exci-
tation for the puriﬁed OxdA and OxdA(CO), and 430 nm excitation
for ferrous OxdA (3 mW for the puriﬁed OxdA and ferrous OxdA, and
0.005 mW for the CO adduct).2.3. Spectral measurements
Resonance Raman spectra were obtained with laser excitation at
413.1 nm with a Krþ laser (Spectra Physics, model 2060) or at
430 nm with a diode laser (Hitachi Metal, 58-BTLR010). The ex-
citation light was focused into the cell, and the laser power was
3 mW at the cell for the isolated and reduced forms of OxdA, but
0.005–0.5 mW for the CO-bound OxdA. The sample solutions for
the Raman measurements were sealed in quartz cells, which were
rotated at 1500 rpm at room temperature. Typically, 50 ll sample
aliquots of 30 lM protein in 100 mM potassium phosphate buﬀer,
pH 7.0, were put into the cell. The scattered light was dispersed
with a single polychromator (Ritsu, DG-1000) equipped with a li-
quid nitrogen-cooled charge-coupled device (CCD) camera. The
spectral slit width was 6 cm1. Raman shifts were calibrated using
indene, CCl4, and an aqueous solution of potassium ferrocyanide as
frequency standards, providing an accuracy of 1 cm1 for intense
isolated lines.3. Results and discussion
3.1. Establishment of a thorough puriﬁcation procedure for
OxdA
We previously reported the use of 2-mercaptoethanol in the
buﬀer for the puriﬁcation of OxdA [31]. However, we found
here that 2-mercaptoethanol was not required for the stability
or activity of the enzyme, rather it led to a decrease in the heme
content. Although the previously puriﬁed enzyme contained
only 0.69 mol of heme/mol of subunit, we have succeeded in
obtaining puriﬁed OxdA containing 1.06 mol of heme/mol of
subunit using the novel puriﬁcation scheme described in Sec-
tion 2. Using the newly puriﬁed OxdA, here, we succeeded in
obtaining ﬁne spectroscopic results for the ﬁrst time.
3.2. High-frequency resonance Raman spectroscopy
It has been established that resonance Raman spectra in the
high-frequency region contain a few marker bands sensitive to
the oxidation state (m4), and spin and coordination states (m2
and m3) of the heme iron in so far known hemoproteins [35].
The resonance Raman spectra in the high-frequency region
(1300–1700 cm1) of the puriﬁed OxdA, a ferrous form (the
active state), and its CO adduct [OxdA(CO)] are shown in
Fig. 1. The puriﬁed OxdA gave m2, m3 and m4 bands at 1574,
1502, and 1376 cm1, respectively. These frequencies suggest
that the puriﬁed OxdA contains a six-coordinate low-spin
ferric heme. The ferrous form, which is the active state of
OxdA, gave m2, m3 and m4 bands at 1557, 1471, and 1358 cm1,
respectively, at typical frequencies of the ﬁve-coordinate high-
spin ferrous hemes. This indicates that ferrous OxdA has a free
distal heme pocket; similar to those of horseradish peroxidase
(HRP) [36] and hemoglobin (Hb) [37], which enables aldoxi-
mes to easily gain access to the heme iron. OxdA(CO) gave m2,
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Fig. 3. The resonance Raman spectra in the Fe–CO stretching and Fe–
C–O bending regions of OxdA(12C16O) and OxdA(13C18O), and their
diﬀerence spectra: (a) OxdA(12C16O); (b) OxdA(13C18O); (c) (a)–(b)
diﬀerence spectrum.
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46 K.-I. Oinuma et al. / FEBS Letters 568 (2004) 44–48m3 and m4 bands at 1576, 1496, and 1373 cm1, respectively, at
frequencies characteristic of a six-coordinate low-spin CO-li-
gated heme. However, OxdA(CO) exhibited extreme photola-
bility, which prevented us from obtaining a Raman spectrum
for the pure CO adduct. For OxdA(CO), therefore, we had to
use very low laser power: 5–10 lW for both the high- and low-
frequency regions. It is worth noting that its photosensitivity is
distinct from that for HRP and Hb, indicating the peculiarity
of the OxdA heme pocket.
3.3. Fe–His stretching mode
The low-frequency resonance Raman spectra of ferrous
OxdA and OxdA(CO) are shown in Fig. 2. An intense band at
226 cm1, which was undetectable with the CO adduct (a), was
observed for ferrous OxdA (d) and the photoproduct (b, c) of
the CO adduct. For the other previously reported hemopro-
teins, the Fe–NHis stretching band is generally observable in
the region from 200 to 230 cm1 for the ﬁve-coordinated fer-
rous hemes containing an imidazole axial ligand but not for
six-coordinated ferrous hemes [38]. We therefore assigned the
226 cm1 band to Fe–His stretching, mFe–His of ferrous OxdA.
This band appears around 220 cm1 when the coordinated
imidazole is not hydrogen bonded but below it when some
strain from protein is present. In contrast, the band is shifted
to a higher frequency when the imidazole is hydrogen bonded.
The observed frequency for OxdA means the presence of a
moderately strong hydrogen bond.
3.4. Fe–C–O modes in the CO-bound OxdA
The CO-isotope dependence of resonance Raman spectra of
OxdA(CO) is shown in Figs. 3 and 4. Isotope shifts of 32 and
20 cm1 were observed for the bands at 512 and 579 cm1,
respectively, upon substitution of 13C18O for 12C16O (Fig. 3).
For the band at 1950 cm1, isotope shifts of 50 and 52 cm1
were observed upon substitution of 13C16O and 12C18O, re-
spectively, for 12C16O (Fig. 4). Based on the frequencies of
these bands and the sizes of the isotope shifts, we assigned the
512, 579, and 1950 cm1 bands to the Fe–CO stretching
(mFe–CO), Fe–C–O bending (dFe–C–O), and C–O stretching (mC–O)
modes, respectively.350300250200
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Fig. 2. Low-frequency regions of resonance Raman spectra of ferrous
OxdA (d) and its CO adduct (a)–(c). The spectra were acquired as
described in Section 2, using 430 nm excitation. Laser power: (a) 0.01
mW; (b) 0.1 mW; (c) 0.5 mW; (d) 3 mW.
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Fig. 4. The resonance Raman spectra in the C–O stretching region of
OxdA(12C16O), OxdA(13C16O), and OxdA(12C18O), and their diﬀer-
ence spectra: (a) OxdA(12C16O); (b) OxdA(13C16O); (c) OxdA(12C18O);
(d) (a)–(b) diﬀerence spectrum; (e) (a)–(c) diﬀerence spectrum.
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Fig. 5. A plot of mFe–CO frequencies against mC–O frequencies observed
for CO-bound hemoproteins. The Raman data for Mycobacterium
tuberculosis hemoglobin (Mt Hb), Paramecium caudatum hemoglobin
(Pc Hb), HemAT-Bs, heme-bound heme oxygenase (HO), soluble
truncated domain of Rhizobium meliloti FixL (Rm FixL*), soluble
guanylate cyclases (sGC1, sGC2), CooA, human Hb A and sperm
whale myoglobin (SwMb) (pH 2.6, 7.0 and 8.4) are cited from [41] and
references therein.
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quencies of the Fe–CO stretching and C–O stretching modes
spanning many diﬀerent heme proteins and model complexes
[39,40]. The correlation depends on the nature of the proximal
ligand; the CO-bound hemes with an imidazole/histidine as the
trans ligand exhibit a correlation line diﬀerent from those with
a thiolate or imidazolate. The mFe–CO and mC–O bands of Ox-
dA(CO), which were detected at 512 and 1950 cm1, respec-
tively, fell on the imidazole/histidine correlation line, as
illustrated in Fig. 5. This ﬁnding conﬁrms our assignment of
neutral imidazole coordination. An additional indication of
the distal heme pocket is also given by the Fe–CO and C–O
stretching modes.
There are two well known factors governing the Fe–CO
stretching frequency in CO-bound heme species. The ﬁrst is the
nature of the axial ligand trans to the bound CO. If the ligand
is a weak electron donor or absent, relatively high frequencies
are found for Fe–CO stretching because the competition for
the metal r orbital is not severe [42]. The second factor is the
polarity of the environment around the bound CO [43–45].
Positive charges near the oxygen atom of CO enhance p-back
bonding from Fe2þ to CO and, as a result, decrease mC–O and
increase mFe–CO. On the other hand, negative charges inhibit the
p-back bonding, and thereby increase mC–O and decrease
mFe–CO. OxdA exhibited a relatively high mFe–His (226 cm1)
compared with other hemoproteins containing an imidazole
axial ligand, and therefore, a weak Fe–CO bond was expected
considering the above mentioned ﬁrst factor governing mFe–CO
frequency. However, the observed mFe–CO of OxdA (512 cm1)
is higher than those of many other hemoproteins which have
weaker Fe–His bond, including myoglobin (mFe–CO ¼ 507
cm1) [43]. Together with the second factor, these ﬁndings for
OxdA indicate that there are positively charged or proton
donating residues in the distal pocket. On the other hand, we
should also notice that there are rare cases where a structural
change in the proximal environment occurs upon CO binding,
aﬀecting the mFe–CO frequency. The Raman data on Alcaligenes
xylosoxidans cytochrome c0 show that the proximal histidine ofthe cytochrome c0 is deprotonated in the ferrous state, but
protonated in the CO adduct, suggesting that the structure in
the proximity of heme changes upon CO binding [46]. In the
case of OxdA, the hydrogen bonding between the proximal
histidine and the counterpart could be broken upon CO
binding, leading to a weakening of the Fe–His bond and the
concomitant increase of the mFe–CO frequency.
In the present study, we have characterized the heme envi-
ronmental structure of OxdA. The axial ligand type of OxdA is
completely diﬀerent from that of the P450 enzymes. In order to
clarify the details of the function and structure of OxdA, site-
directed mutagenesis, further spectroscopic analysis, and the X
ray crystallography of OxdA are currently in progress.
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